These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cancer antigen-125 is a predictor of mortality in patients with pulmonary arterial hypertension. Sahin A; Kaya H; Avci O Clin Biochem; 2021 Mar; 89():58-62. PubMed ID: 33382999 [TBL] [Abstract][Full Text] [Related]
3. Mid-arm and calf circumferences are stronger mortality predictors than body mass index for patients with chronic obstructive pulmonary disease. Ho SC; Wang JY; Kuo HP; Huang CD; Lee KY; Chuang HC; Feng PH; Chen TT; Hsu MF Int J Chron Obstruct Pulmon Dis; 2016; 11():2075-80. PubMed ID: 27621613 [TBL] [Abstract][Full Text] [Related]
4. Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD. Hu G; Wu Y; Zhou Y; Wu Z; Wei L; Li Y; Peng G; Liang W; Ran P Int J Chron Obstruct Pulmon Dis; 2016; 11():2729-2736. PubMed ID: 27843309 [TBL] [Abstract][Full Text] [Related]
5. Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations. Avriel A; Rozenberg D; Raviv Y; Heimer D; Bar-Shai A; Gavish R; Sheynin J; Douvdevani A Int J Chron Obstruct Pulmon Dis; 2016; 11():3153-3161. PubMed ID: 28003743 [TBL] [Abstract][Full Text] [Related]
6. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia. Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709 [TBL] [Abstract][Full Text] [Related]
7. Midregional proatrial natriuretic peptide predicts survival in exacerbations of COPD. Bernasconi M; Tamm M; Bingisser R; Miedinger D; Leuppi J; Müller B; Christ-Crain M; Stolz D Chest; 2011 Jul; 140(1):91-99. PubMed ID: 21106656 [TBL] [Abstract][Full Text] [Related]
8. Preoperative spirometry results as a determinant for long-term mortality after EVAR for AAA. Ohrlander T; Dencker M; Acosta S Eur J Vasc Endovasc Surg; 2012 Jan; 43(1):43-7. PubMed ID: 22051733 [TBL] [Abstract][Full Text] [Related]
9. Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type. Grolimund E; Kutz A; Marlowe RJ; Vögeli A; Alan M; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Zimmerli W; Mueller B; Schuetz P; COPD; 2015 Jun; 12(3):295-305. PubMed ID: 25230352 [TBL] [Abstract][Full Text] [Related]
10. High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study. Sand JM; Leeming DJ; Byrjalsen I; Bihlet AR; Lange P; Tal-Singer R; Miller BE; Karsdal MA; Vestbo J Respir Res; 2016 Oct; 17(1):125. PubMed ID: 27716343 [TBL] [Abstract][Full Text] [Related]
11. Activation of the Serotonin Pathway is Associated with Poor Outcome in COPD Exacerbation: Results of a Long-Term Cohort Study. Meier MA; Ottiger M; Vögeli A; Steuer C; Bernasconi L; Thomann R; Christ-Crain M; Henzen C; Hoess C; Zimmerli W; Huber A; Mueller B; Schuetz P Lung; 2017 Jun; 195(3):303-311. PubMed ID: 28434116 [TBL] [Abstract][Full Text] [Related]
12. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease. Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798 [TBL] [Abstract][Full Text] [Related]
13. Serum CA-125 level in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension. Rahimi-Rad MH; Rahimi P; Rahimi B; Gholamnaghad M Pneumologia; 2014; 63(3):164-6. PubMed ID: 25420291 [TBL] [Abstract][Full Text] [Related]
14. The prognostic role of chronic obstructive pulmonary disease in ST-elevation myocardial infarction after primary angioplasty. Lazzeri C; Valente S; Attanà P; Chiostri M; Picariello C; Gensini GF Eur J Prev Cardiol; 2013 Jun; 20(3):392-8. PubMed ID: 22023803 [TBL] [Abstract][Full Text] [Related]
15. Independent risk factors for mortality in patients with chronic obstructive pulmonary disease who undergo comprehensive cardiac evaluations. Ahn YH; Lee KS; Park JH; Jung JH; Lee M; Jung YJ; Chung WY; Sheen S; Park KJ; Kim DJ; Kang DR; Lee JD; Yoon S; Jin XJ; Yang HM; Lim HS; Park JS; Shin JH; Tahk SJ Respiration; 2015; 90(3):199-205. PubMed ID: 26278777 [TBL] [Abstract][Full Text] [Related]
16. Hyperuricemia is a biomarker of early mortality in patients with chronic obstructive pulmonary disease. Zhang X; Liu L; Liang R; Jin S Int J Chron Obstruct Pulmon Dis; 2015; 10():2519-23. PubMed ID: 26648710 [TBL] [Abstract][Full Text] [Related]
17. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes. Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967 [TBL] [Abstract][Full Text] [Related]
18. The value of assessment tests in patients with acute exacerbation of chronic obstructive pulmonary disease. Zhao YF; Jiang YP; Zhou LF; Wu XL Am J Med Sci; 2014 May; 347(5):393-9. PubMed ID: 24270077 [TBL] [Abstract][Full Text] [Related]
20. [Long-term follow-up study of moderate chronic obstructive pulmonary disease in elderly patients]. Xiang PC; Yao Z; Cheng XS; Zhang EM; Zhang X; Song LP; Ju LX; Ding Y; Zhang Y Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep; 29(9):583-6. PubMed ID: 17129462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]